Development of New Amlodipine Complex using Ion Exchange Resin
![]() |
Jeong, Sang-Young
(Central R&D Center, Korea United Pharm. Inc.)
Ahn, Ki-Young (Central R&D Center, Korea United Pharm. Inc.) Ahn, Geon-Seok (Central R&D Center, Korea United Pharm. Inc.) Gil, Young-Sig (Central R&D Center, Korea United Pharm. Inc.) Hwang, Sung-Joo (National Research Lab. of Pharmaceutical Technology, College of Pharmacy, Chungnam National University) |
1 | H. Kudat, N. Eren and F. Erzengin, Efficacy and tolerability of amlodipine in patients with stable angina pectoris, and open-label, mutilcenter trial, Curr. Ther. Res., 59, 215-222 (1998) DOI ScienceOn |
2 | R. A. Burges, D. G. Gardiner, M. Gwilt, M., A. J. Higgins, K. J. Blackburn, S. F. Campbell, P. E. Cross and J. K. Stubbs, Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors, J. Cardiovasc. Pharmacol., 9, 110-119 (1987) |
3 | D. R. Abernethy, The pharmacokinetic profile of amlodipine, Am. Heart J., 118, 1100-1103. DOI ScienceOn |
4 | 에드워드 데이비슨, 제임스 인그램 웰리스, 암로디핀 베실레 이트염의 제조방법, 대한민국특허청, 특1995-0006710(1995) |
5 | 레멘스야코부스마리아, 반달렌프란스, 반데르하이덴아를레테, 암로디핀 말레이트를 포함하는 약학 조성물, 대한민국특허청, 특2003-0070594(2003) |
6 | N. Brudney, Ion exchange resin complexes in oral therapy, Can. Pharm. J., 45, 245-248 (1959) |
7 | 우종수, 구자성, 마크로라이드계 항생제의 경구투여용 조성물 및 이의 제조방법, 대한민국특허청, 특2002-0016067(2002) |
8 | Y. Raghunathan, L. P. Amsel, O. N. Hinsvark, and W. Bryant, Sustained-release drug delivery system I : Coated ion exchange resin system for phenylpropanolamine and other drugs, J. Phar. Sci., 70(4), 379-384 (1981) DOI |
9 | Leo Corporation, Smoking substitutes and method of production, Patent GB 1,1325,011(1973) |
10 | J. Y. Park, K. H. Kim, G. S. Lee, P. W. Park, S. Kim, Y. S. Lee, Y. W. Lee and E. K. Shin, Randomized, Open label Two period crossover comparison of the Pharmacokinetics and Pharmacodynamic properties of two amlodipine formulation in healthy adult male Korean subjects, Clin. Ther., 26, 715-723 (2004). DOI ScienceOn |
11 | P. Gyselnck, R. Vanseveren, P. Braeckman and E. Schacht, Drug-polymer combinations. The preparation of sustained release drugs by combination with ion exchange resins, Pharmazie., 36, 769-772 (1981) |
12 | S. J. Douglas, Glaxo Group Research Ltd., Process for the preparation of a ranitidine resin absorbate, EP 0431759(1990) |
13 | S. Borodkin and D. P. Sundberg, Chewable tablets including coated particle of psuedoepherine-weak cation exchange resin, Patent US 3,594,470 (1971) |
14 | D. S. Shin, W. H. Song and Y. W. Choi, Drug release characteristics of famotidine-cation exchange resin complex and their pharmacokinetics in rats, J. Kor. Pharm. Sci., 27, 313-321 (1997) |
15 | 베스 에스, 쿨카니 니마, 앰바이크 에이치, 람세이 폴, 맛 차단 제로서 이온 교환 수지를 함유하는 고속 용해 경구소모 필름, 대한민국특허청, 특2002-0084233(2002) |
![]() |